BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1883797)

  • 1. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding.
    Chamberlain G; Freeman R; Price F; Kennedy A; Green D; Eve L
    Br J Obstet Gynaecol; 1991 Jul; 98(7):707-11. PubMed ID: 1883797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid.
    Bonnar J; Sheppard BL
    BMJ; 1996 Sep; 313(7057):579-82. PubMed ID: 8806245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing treatments for menorrhagia.
    Chamberlain G
    Nurs Times; 1992 Mar 11-17; 88(11):46. PubMed ID: 1297082
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of mefenamic acid in patients with a complaint of menorrhagia.
    Fraser IS; Pearse C; Shearman RP; Elliott PM; McIlveen J; Markham R
    Obstet Gynecol; 1981 Nov; 58(5):543-51. PubMed ID: 7029369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of menorrhagia with mefenamic acid.
    Fraser IS; McCarron G; Markham R; Robinson M; Smyth E
    Obstet Gynecol; 1983 Jan; 61(1):109-12. PubMed ID: 6337354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between mefenamic acid and danazol in the treatment of established menorrhagia.
    Dockeray CJ; Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1989 Jul; 96(7):840-4. PubMed ID: 2765430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations.
    Haynes PJ; Flint AP; Hodgson H; Anderson AB; Dray F; Turnbull AC
    Int J Gynaecol Obstet; 1980; 17(6):567-72. PubMed ID: 6106574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia.
    Harrison RF; Cambell S
    Lancet; 1976 Aug; 2(7980):283-5. PubMed ID: 59855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid.
    Hall P; Maclachlan N; Thorn N; Nudd MW; Taylor CG; Garrioch DB
    Br J Obstet Gynaecol; 1987 Jun; 94(6):554-8. PubMed ID: 3304401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of mefenamic acid and norethisterone on measured menstrual blood loss.
    Cameron IT; Haining R; Lumsden MA; Thomas VR; Smith SK
    Obstet Gynecol; 1990 Jul; 76(1):85-8. PubMed ID: 2359570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent.
    Garay RP; Chiavaroli C; Hannaert P
    Am J Ther; 2006; 13(3):236-47. PubMed ID: 16772766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrinolytics for heavy menstrual bleeding.
    Lethaby A; Farquhar C; Cooke I
    Cochrane Database Syst Rev; 2000; (4):CD000249. PubMed ID: 11034679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia.
    van Eijkeren MA; Christiaens GC; Geuze HJ; Haspels AA; Sixma JJ
    Am J Obstet Gynecol; 1992 May; 166(5):1419-28. PubMed ID: 1595797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cyclical menorrhagia with prostaglandin synthetase inhibitor.
    Grover V; Usha R; Gupta U; Kalra S
    Asia Oceania J Obstet Gynaecol; 1990 Sep; 16(3):255-9. PubMed ID: 2088249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Alleviation of IUD menorrhagia with ethamsylate.
    Harrison RF; Campbell S
    Br Med J; 1976 Mar; 1(6010):649-50. PubMed ID: 766907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of etamsylate in intrauterine-device menorrhagia.
    Kovács L; Annus J
    Gynecol Invest; 1978; 9(4):161-5. PubMed ID: 374202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors.
    Anderson AB; Haynes PJ; Guillebaud J; Turnbull AC
    Lancet; 1976 Apr; 1(7963):774-6. PubMed ID: 56590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study.
    Mercorio F; De Simone R; Di Carlo C; Bifulco G; Tessitore G; Di Spiezio Sardo A; Nappi C
    Hum Reprod; 2003 Nov; 18(11):2319-22. PubMed ID: 14585881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ethamsylate and aminocaproic acid on menstrual blood loss in women using intrauterine devices.
    Kasonde JM; Bonnar J
    Br Med J; 1975 Oct; 4(5987):21-2. PubMed ID: 1174906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.